Details of the Drug

General Information of Drug (ID: DMKO0BQ)

Drug Name

BLD-2660

Synonyms

BLD 2660

Indication

Disease Entry	ICD 11	Status	REF
Coronavirus Disease 2019 (COVID-19)	1D6Y	Phase 2	[1]
------------------------------------------------------------------------------------

Therapeutic Class

Antiviral Agents

Drug Type

Small molecular drug

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
HUMAN calpain-1/calpain small subunit 1 heterodimer (CAPN1/CAPNS1)	TT45V0U	CAN1_HUMAN/CPNS1_HUMAN	Inhibitor	[1]
HUMAN calpain-2/calpain small subunit 1 heterodimer (CAPN2/CAPNS1)	TTO361H	CAN2_HUMAN/CPNS1_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT04334460) Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects. U.S. National Institutes of Health.